Standard InChI: InChI=1S/C21H28N4O4S3/c1-12(2)17-19(27)29-13(6-4-5-7-30)8-15(26)22-9-16-23-14(10-31-16)18-25-21(3,11-32-18)20(28)24-17/h4,6,10,12-13,17,30H,5,7-9,11H2,1-3H3,(H,22,26)(H,24,28)/b6-4+/t13-,17-,21+/m1/s1
1.Benelkebir H, Marie S, Hayden AL, Lyle J, Loadman PM, Crabb SJ, Packham G, Ganesan A.. (2011) Total synthesis of largazole and analogues: HDAC inhibition, antiproliferative activity and metabolic stability., 19 (12):[PMID:21420302][10.1016/j.bmc.2011.02.024]
2.Chen F, Chai H, Su MB, Zhang YM, Li J, Xie X, Nan FJ.. (2014) Potent and orally efficacious bisthiazole-based histone deacetylase inhibitors., 5 (6):[PMID:24944733][10.1021/ml400470s]
3.Kim B, Park H, Salvador LA, Serrano PE, Kwan JC, Zeller SL, Chen QY, Ryu S, Liu Y, Byeon S, Luesch H, Hong J.. (2014) Evaluation of class I HDAC isoform selectivity of largazole analogues., 24 (16):[PMID:25070421][10.1016/j.bmcl.2014.07.006]
4.Salvador LA, Park H, Al-Awadhi FH, Liu Y, Kim B, Zeller SL, Chen QY, Hong J, Luesch H.. (2014) Modulation of Activity Profiles for Largazole-Based HDAC Inhibitors through Alteration of Prodrug Properties., 5 (8):[PMID:25147612][10.1021/ml500170r]